FDA.reportPublic FDA data

linaclotide 0.072 MG Oral Capsule [Linzess]

RxCUI
1869699
RxNorm name
linaclotide 0.072 MG Oral Capsule [Linzess]
Display name
linaclotide 0.072 MG Oral Capsule [Linzess]
Full name
linaclotide 0.072 MG Oral Capsule [Linzess]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:46

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
09beda19-56d6-4a56-afdc-9a77b70b2ef3Linzess 72 MCG Oral Capsule [PSN] · linaclotide 0.072 MG Oral Capsule [Linzess] [SBD] · Linzess 0.072 MG Oral Capsule [SY] · Linzess 72 MCG Oral Capsule [SY]439These highlights do not include all the information needed to use LINZESS safely and effectively. See full prescribing information for LINZESS . LINZESS ® ( linaclotide ) capsules, for oral use Initial U.S. Approval: 201220260521